Presentation and Outcomes of S1P-RM- and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology(R) Neuroimmunology & Neuroinflammation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study
Neurol Neuroimmunol Neuroinflamm 2024 Sep 01;11(5)e200281, JC Blant, NN De Rossi, R Gold, A Maurousset, M Kraemer, L Romero-Pinel, T Misu, JC Ouallet, M Pallix Guyot, S Gerevini, C Bakirtzis, R Piñar Morales, B Vlad, P Karypidis, X Moisset, TJ Derfuss, I Jelcic, G Martin-Blondel, I Ayzenberg, C McGraw, DA Laplaud, RA Du Pasquier, R Bernard-ValnetFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.